BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 18711012)

  • 1. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2008 Sep; 118(10):993-1001. PubMed ID: 18711012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
    Mora S; Rifai N; Buring JE; Ridker PM
    Clin Chem; 2009 May; 55(5):888-94. PubMed ID: 19395440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter by Lund et al regarding article, "fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events".
    Lund SS; Vaag AA; Jensen T
    Circulation; 2009 Apr; 119(13):e384; author reply e385. PubMed ID: 19349329
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
    Langsted A; Nordestgaard BG
    Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
    Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC;
    Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfasting hyperlipidemia and cardiovascular disease.
    Nordestgaard BG; Langsted A; Freiberg JJ
    Curr Drug Targets; 2009 Apr; 10(4):328-35. PubMed ID: 19355857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
    Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
    Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ
    Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
    Parish S; Offer A; Clarke R; Hopewell JC; Hill MR; Otvos JD; Armitage J; Collins R;
    Circulation; 2012 May; 125(20):2469-78. PubMed ID: 22539783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
    Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
    Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.